Market Report, "Metabolomic Technologies Inc. - Product Pipeline Analysis, 2013 Update", published

Metabolomic Technologies Inc. (MTI) is a biotechnology company. The company develops diagnostic tests to detect adenomatous polyps and colorectal cancer. Its products include variety of diagnostics. MTI offers products under various brands such as BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx, IBDDx, LactoseDx, RefluxDx and UlcerDx. The company offers biomarker validation services. Its products are used to treat breast cancer, prostate cancer, celiac disease, ulcerative colitis, Crohn's Disease, IBD, lactose intolerance, acid reflux and gastric ulcers. The company conducts research and development program to identify metabolomic fingerprints in urine samples. It has basic research laboratory facilities and supplies, clinical trial facilities and supplies, and NMR facilities. MTI is headquartered in Edmonton, Alberta, Canada.

Full Report Details at
- http://www.fastmr.com/prod/761335_metabolomic_technologies_inc_product_pipeline.aspx?afid=301

This report is a source for data, analysis and actionable intelligence on the Metabolomic Technologies Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.<\li> * Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.<\li> * Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.<\li> * Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.<\li> * Data on relevant clinical trials and product patent details, wherever applicable.<\li> * Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Biocrates Life Sciences AG - Product Pipeline Analysis, 2013 Update
- Covalon Technologies Ltd. (COV) - Product Pipeline Analysis, 2013 Update
- Alfa Wassermann Diagnostic Technologies, LLC - Product Pipeline Analysis, 2013 Update
- Bioject Medical Technologies Inc. (BJCT) - Product Pipeline Analysis, 2013 Update
- Tissue Regeneration Technologies, LLC - Product Pipeline Analysis, 2013 Update